Home / Articles (page 2)

Articles

Digital Diabetes Coaching: Why an App Alone Isn’t Enough

Person with type 2 diabetes using a digital health app while receiving virtual diabetes coaching and tracking healthy lifestyle goals.

A diabetes app can track meals, count steps, log glucose, and deliver reminders. However, can an app actually help someone turn all that information into lasting daily habits? A recent randomized controlled trial suggests that digital diabetes coaching, with technology supported by ongoing human guidance, may help bridge that gap. …

Read More »

More Dietary Fat, Worse Blood Fats? A Low-Carb Diabetes Trial Challenges the Assumption

Low-carb foods including salmon, avocado, nuts, vegetables, and olive oil beside a glucose meter and heart health chart.

Does eating more fat automatically mean that more harmful fatty acids will circulate in the blood? A new randomized trial suggests the answer may be more complicated. Researchers studying a low-carb diet for type 2 diabetes found that six months of carbohydrate restriction changed circulating fatty acids in potentially favorable …

Read More »

Beyond Blood Sugar: What Personalized Nutrition May Be Doing to Inflammation

Personalized medical nutrition therapy for diabetes featuring a healthy balanced meal and concepts related to blood sugar, inflammation, and metabolic health.

Medical nutrition therapy for diabetes is often discussed in terms of A1C, glucose levels, and weight. However, could personalized nutrition also influence inflammation and other aspects of metabolic health? A recent randomized controlled trial offers an intriguing reason to ask that question. Researchers found that individualized medical nutrition therapy with …

Read More »

Not All Insulin Resistance Is the Same: Why Fat and Muscle May Matter Differently

Medical illustration comparing tissue-specific insulin resistance in adipose tissue and skeletal muscle and their different responses to insulin.

Insulin resistance is often discussed as though it were one metabolic problem affecting the entire body equally. However, emerging research suggests the picture is more complex. Tissue-specific insulin resistance means that fat, muscle, the liver, and other tissues may not respond to insulin in the same way. More importantly, resistance …

Read More »

Human vs. Analogue Insulin: Does Newer Really Mean Better for Type 1 Diabetes?

Human insulin and analogue insulin options used in Type 1 diabetes treatment

The choice of human vs analogue insulin is especially important for people with Type 1 diabetes who live where healthcare resources are limited. Analogue insulins are often preferred because their action can be more predictable and flexible. However, human insulin is generally less expensive and may be easier for health …

Read More »

When “Type 2” Isn’t Type 2: Clues to Type 3c Diabetes

Pancreas model, glucose meter, and clinical assessment representing type 3c diabetes diagnosis and pancreatogenic diabetes.

A patient develops diabetes in adulthood, so Type 2 diabetes may seem like the obvious diagnosis. However, what if that patient also has chronic pancreatitis, unexplained weight loss, pancreatic surgery, or symptoms of poor nutrient absorption? Those details can change the clinical picture. Careful evaluation can reveal Type 3c diabetes …

Read More »

One Drug Isn’t Enough: When Should Clinicians Combine Treatments for Painful Diabetic Neuropathy?

Clinician discussing diabetic neuropathy pain treatment and combination therapy options with a patient using an anatomical foot model.

Finding the right diabetic neuropathy pain treatment can be challenging when a well-chosen first medication provides only partial relief. Burning, shooting pain, tingling, and allodynia can continue to disrupt sleep, mobility, mood, and daily function. Fortunately, clinicians do not always have to choose between abandoning a partially effective drug and …

Read More »

Which Diabetes Drug Will Work Best? New Research Puts Precision Prescribing to the Test

Precision diabetes treatment concept showing sitagliptin, canagliflozin, and pioglitazone with glucose monitoring and personalized care tools.

Precision diabetes treatment aims to answer a question clinicians and patients face every day: which diabetes drug is most likely to work best for this particular person? A new analysis from the TriMaster crossover trial offers an important clue. Researchers compared several precision-medicine strategies for predicting responses to sitagliptin, canagliflozin, …

Read More »

Why Does Eating Less Improve Insulin Sensitivity? Ceramides May Hold Part of the Answer

Healthy meal illustrating how calorie restriction may affect ceramides, adiponectin, and insulin sensitivity.

Why does eating less sometimes improve insulin sensitivity beyond what we might expect from weight loss alone? Human research points to an intriguing connection between ceramides, insulin resistance, and adiponectin. Findings from the CALERIE research program suggest that sustained, moderate calorie restriction changes circulating bioactive lipids in ways that may …

Read More »